SUSAN BOGGS: Open Payments
NPI 1225029903 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 17 payments from 9 companies in 2025. Trend: 2023 $427 · 2024 $340 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $60 |
| Novartis Pharmaceuticals Corporation | 3 | $44 |
| Astellas Pharma US Inc | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Lilly USA, LLC | 2 | $33 |
| Exact Sciences Corporation | 1 | $32 |
| Corcept Therapeutics | 2 | $32 |
| Abbott Laboratories | 1 | $20 |
| ABBVIE INC. | 1 | $16 |
Products named: LEQVIO, Veozah, AIRSUPRA, MOUNJARO, Cologuard Collection Kit, Korlym, Ozempic, FREESTYLE LIBRE 3.
Industry payments across NJ — which companies pay providers there.
